Economic Evaluation of ASCOT-BPLA: Antihypertensive Treatment With an Amlodipine-Based Regimen Is Cost Effective Compared With an Atenolol-Based Regimen

Heart- United Kingdom

doi 10.1136/hrt.2007.127217

Full Text

Abstract

Available in

Date

Authors

Publisher

BMJ


Related search